Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Equity (2023 - 2025)

CG Oncology (CGON) has disclosed Return on Equity for 3 consecutive years, with 0.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 8.0% year-over-year to 0.22%, compared with a TTM value of 0.22% through Dec 2025, down 8.0%, and an annual FY2025 reading of 0.22%, up 7.0% over the prior year.
  • Return on Equity was 0.22% for Q4 2025 at CG Oncology, roughly flat from 0.22% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.42% in Q4 2023 and bottomed at 0.25% in Q1 2024.
  • Average Return on Equity over 3 years is 0.11%, with a median of 0.15% recorded in 2025.
  • The sharpest move saw Return on Equity tumbled -56bps in 2024, then grew 11bps in 2025.
  • Year by year, Return on Equity stood at 0.42% in 2023, then tumbled by -133bps to 0.14% in 2024, then plummeted by -61bps to 0.22% in 2025.
  • Business Quant data shows Return on Equity for CGON at 0.22% in Q4 2025, 0.22% in Q3 2025, and 0.19% in Q2 2025.